Hira Khalid

Ms. Hira Khalid

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2013 in Journal of Analytical Methods in Chemistry
Verified
Journal Article
Open access
PDF file
NHNajmul Hasan
Najmul Hasan
MCMathurot Chaiharn
Mathurot Chaiharn
SKSauleha Khan
Sauleha Khan
HKHira Khalid
Hira Khalid
NSNawab Sher
Nawab Sher
Muhammad Zain SiddiquiMuhammad Zain Siddiqui
Muhammad Zain Siddiqui
A reverse phase stability indicating HPLC method for simultaneous determination of two antispasmodic drugs in pharmaceutical parenteral dosage forms (injectable) and in serum has been developed and validated. Mobile phase ingredients consist of Acetonitrile:buffer:sulfuric acid 0.1M (50:50:0.3 v/v/v), at flow rate 1.0mL/min using a Hibar μBondapak ODS C18 column monitored at dual wavelength of 266nm and 205nm for phloroglucinol and trimethylphloroglucinol, respectively. The drugs were subjected to stress conditions of hydrolysis (oxidation, base, acid, and thermal degradation). Oxidation degraded the molecule drastically while there was not so much significant effect of other stress conditions. The calibration curve was linear with a correlation coefficient of 0.9999 and 0.9992 for PG and TMP, respectively. The drug recoveries fall in the range of 98.56% and 101.24% with 10pg/mL and 33pg/mL limit of detection and limit of quantification for both phloroglucinol and trimethylphloroglucinol. The method was validated in accordance with ICH guidelines and was applied successfully to quantify the amount of trimethylphloroglucinol and phloroglucinol in bulk, injectable form and physiological fluid. Forced degradation studies proved the stability indicating abilities of the method.

13 August 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
FAFahad Amin
Fahad Amin
HKHira Khalid
Hira Khalid
MKMaliha Khalid
Maliha Khalid
MTMuhammad Talha
Muhammad Talha
AWAminath Waafira
Aminath Waafira
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare, rapidly progressive malignancy-related pulmonary vascular condition that remains difficult to diagnose before death due to its nonspecific clinical and imaging features. Recent advances in metabolomics, particularly when powered by artificial intelligence (AI), offer promising opportunities for early detection by identifying distinct metabolic signatures. While AI-driven metabolomics has shown success in various cancers, its application to PTTM is challenged by the rarity of the disease, limited datasets, and privacy concerns. Innovations such as multicenter collaborations and blockchain-based data sharing may help overcome these barriers. Integrating AI and metabolomics has the potential to revolutionize not only the diagnosis of PTTM but also other rare diseases with elusive early biomarkers.


30 October 2025 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
RARifqa Amjad
Rifqa Amjad
MAMuhammad Usama Afzal
Muhammad Usama Afzal
WMWaqar Muhammad
Waqar Muhammad
MKMohammad Adil Khan
Mohammad Adil Khan
MBMansoor Ijaz Bhatti
Mansoor Ijaz Bhatti
HKHira Khalid
Hira Khalid

1 May 2026
Verified
Journal Article
Open access
ZHZubia Hassan
Zubia Hassan
VFVaniza Farrukh
Vaniza Farrukh
SKSanjeet Kumar
Sanjeet Kumar
EEEmmanuel Edigberhi
Emmanuel Edigberhi
HKHira Khalid
Hira Khalid
OOOsamagbe Osaghae
Osamagbe Osaghae
Was not provided for this article.

23 March 2026 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
PDF file
AOArienmughare Oghenetega
Arienmughare Oghenetega
NBNimrah Bhatti
Nimrah Bhatti
HKHira Khalid
Hira Khalid
EEEmmanuel Edigberhi
Emmanuel Edigberhi
OOOsamagbe Osaghae
Osamagbe Osaghae
KSKhurrum Shabbir
Khurrum Shabbir